2025: The Year Patent Gender Medicine Fraud Was Finally Prosecuted

And what that means for The Distance

During October, the U.S. Department of Justice charged Children’s Hospital of Philadelphia (CHOP) and Children’s Hospital of Pittsburgh with “fraudulent billing practices.”

Lisa Hsiao, who runs the Department of Justice office that used to be called the Consumer Protection Branch, cited “off-label uses” of puberty blockers prescribed with an “incorrect diagnosis and/or billing code” when clinicians “know that certain insurance plans may not cover off-label prescription of puberty blockers or cross-sex hormones for gender-related treatment.”

Now titled the Enforcement and Affirmative Litigation Branch, Hsiao’s office searched “extensive anonymized insurance claims” to find 250 minors with central precocious puberty at age 10 or older “including numerous teenagers aged 14 to 18” from 2017 to 2024. This is patent medical fraud.

With the assistance of a federal judge, CHOP and CHP are still resisting the Trump administration’s efforts to identify those patients, calling them “invasive”. Ad…